COVID-19 and the cardiovascular system

Cited by (1,006)

Items 801–900 of 1,006

1. Association between living in municipalities with high crowding conditions and poverty and mortality from COVID-19 in Mexico
   Viridiana Ríos, Edgar Denova‐Gutiérrez, Sı́món Barquera · 2022 · PLoS ONE
2. ACE2 polymorphisms and individual susceptibility to SARS-CoV-2 infection: insights from an in silico study
   Matteo Calcagnile, Patricia Forgez, Antonio Iannelli, Cecilia Bucci, Marco Alifano, Pietro Alifano · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
3. Evidence for Use or Disuse of Renin–Angiotensin System Modulators in Patients Having COVID-19 With an Underlying Cardiorenal Disorder
   Himanshu Sankrityayan, Ajinath Kale, Nisha Sharma, Hans‐Joachim Anders, Anil Bhanudas Gaikwad · 2020 · Journal of Cardiovascular Pharmacology and Therapeutics
4. Going viral: A brief history of Chilblain-like skin lesions (“COVID toes”) amidst the COVID-19 pandemic
   Paul R. Massey, Krystal M. Jones · 2020 · Seminars in Oncology
5. The renin–angiotensin–aldosterone system as a link between obesity and coronavirus disease 2019 severity
   Ioannis Akoumianakis, Theodosios D. Filippatos · 2020 · Obesity Reviews
6. Prevalence of Cardiovascular Comorbidities in Coronavirus Disease 2019, Severe Acute Respiratory Syndrome, and Middle East Respiratory Syndrome: Pooled Analysis of Published Data
   Yang Liu, Shaohui Wu, Mu Qin, Weifeng Jiang, Xu Liu · 2020 · Journal of the American Heart Association
7. Relationship between anosmia and hospitalisation in patients with coronavirus disease 2019: an otolaryngological perspective
   Hakan Avcı, Burak Karabulut, Abdussamet Faraşoğlu, Eren Boldaz, Melis Demirağ Evman · 2020 · The Journal of Laryngology & Otology
8. A Web-Based Platform on Coronavirus Disease-19 to Maintain Predicted Diagnostic, Drug, and Vaccine Candidates
   Sumeet Patiyal, Dilraj Kaur, Harpreet Kaur, Neelam Sharma, Anjali Dhall, Sukriti Sahai, Piyush Agrawal, Lubna Maryam, Chakit Arora, Gajendra P. S. Raghava · 2020 · Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
9. SARS-CoV-2 Infection and Cardioncology: From Cardiometabolic Risk Factors to Outcomes in Cancer Patients
   Vincenzo Quagliariello, Annamaria Bonelli, Antonietta Caronna, Gabriele Conforti, Martina Iovine, Andreina Carbone, Massimiliano Berretta, Gerardo Botti, Nicola Maurea · 2020 · Cancers
10. Screened antipsychotic drugs inhibit SARS-CoV-2 binding with ACE2 in vitro
    Jiayu Lu, Yajing Hou, Shuai Ge, Xiangjun Wang, Jue Wang, Tian Hu, Yuexin Lv, Huaizhen He, Cheng Wang · 2020 · Life Sciences
11. Left ventricular longitudinal strain alterations in asymptomatic or mildly symptomatic paediatric patients with SARS-CoV-2 infection
    Domenico Sirico, Costanza Di Chiara, Paola Costenaro, Francesco Bonfante, Sandra Cozzani, Mario Plebani, Elena Reffo, Biagio Castaldi, Daniele Donà, Liviana Da Dalt et al. · 2021 · European Heart Journal - Cardiovascular Imaging
12. Pulmonary, cardiac and renal distribution of ACE2, furin, TMPRSS2 and ADAM17 in rats with heart failure: Potential implication for COVID‐19 disease
    Emad E. Khoury, Yara Knaney, Ahmad Fokra, Safa Kinaneh, Zaher S. Azzam, Samuel Noam Heyman, Zaid A. Abassi · 2021 · Journal of Cellular and Molecular Medicine
13. ACE2 correlates with immune infiltrates in colon adenocarcinoma: Implication for COVID-19
    Mohsen Ahmadi, Salar Pashangzadeh, Pegah Mousavi, Negin Saffarzadeh, Mohammad Amin Habibi, Fatemeh Hajiesmaeili, Nima Rezaei · 2021 · International Immunopharmacology
14. Repurposing Chloroquine Against Multiple Diseases With Special Attention to SARS-CoV-2 and Associated Toxicity
    Siya Kamat, Madhuree Kumari · 2021 · Frontiers in Pharmacology
15. Human cell receptors: potential drug targets to combat COVID-19
    Pawan Kumar Raghav, Keerthana Kalyanaraman, Dinesh Kumar · 2021 · Amino Acids
16. Echocardiographic Characteristics and Outcome in Patients With COVID-19 Infection and Underlying Cardiovascular Disease
    Yuman Li, Lingyun Fang, Shuangshuang Zhu, Yuji Xie, Bin Wang, Lin He, Danqing Zhang, Yongxing Zhang, Hongliang Yuan, Chun Wu et al. · 2021 · Frontiers in Cardiovascular Medicine
17. Adverse Cardiovascular Effects of Anti-COVID-19 Drugs
    Dongling Liu, Xiang Zeng, Zufeng Ding, Fenghua Lv, Jawahar L. Mehta, Xianwei Wang · 2021 · Frontiers in Pharmacology
18. A Passive Smart Face Mask for Wireless Cough Monitoring: A Harmonic Detection Scheme With Clutter Rejection
    Liang Zhu, Trung Dung Ha, Yi-Huan Chen, Haiyu Huang, Pai‐Yen Chen · 2022 · IEEE Transactions on Biomedical Circuits and Systems
19. Transcriptomic profiling of cardiac tissues from SARS‐CoV ‐2 patients identifies DNA damage
    Arutha Kulasinghe, Ning Liu, Chin Wee Tan, James H. Monkman, Jane E. Sinclair, Dharmesh Dinesh Bhuva, David Godbolt, Liuliu Pan, Andy Nam, Habib Sadeghirad et al. · 2022 · Immunology
20. Association of ACE2 Gene Variants with the Severity of COVID-19 Disease—A Prospective Observational Study
    Jerzy Sieńko, Izabela Marczak, Maciej Józef Kotowski, Anna Bogacz, Karol Tejchman, Magdalena Sieńko, Katarzyna Kotfis · 2022 · International Journal of Environmental Research and Public Health
21. Natural Language Processing for Improved Characterization of COVID-19 Symptoms: Observational Study of 350,000 Patients in a Large Integrated Health Care System
    Deborah E. Malden, Sara Yee Tartof, Bradley K. Ackerson, Vennis X. Hong, Jacek Skarbinski, Vincent Yau, Lei Qian, Heidi J. Fischer, Sally Fontamillas Shaw, Susan L. Caparosa et al. · 2022 · JMIR Public Health and Surveillance
22. Relating human physiology content to COVID-19: a strategy to keep students in touch with physiology in times of social distance due to pandemic
    Niége Alves, Guilherme Salgado Carrazoni, Caroline Bitencourt Soares, Ana Carolina de Souza da Rosa, Náthaly Marks Soares, Pâmela Billig Mello‐Carpes · 2021 · AJP Advances in Physiology Education
23. Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19
    Chia Siang Kow, Syed Tabish Razi Zaidi, Syed Shahzad Hasan · 2020 · American Journal of Cardiovascular Drugs
24. Coronavirus Disease 2019 (COVID-19) from the point of view of Neurologists: Consideration of Neurological Findings and Symptoms during the Combat against a Pandemic
    Ayşe Nur Özdağ Acarlı, Bedia Samancı, Esme Ekizoğlu, Arman Çakar, Nermi̇n Görkem Şi̇ri̇n, Tuncay Gündüz, Yeşim Parman, Betül B. Baykan · 2020 · Nöro Psikiyatri Arşivi
25. Call to Action: SARS-CoV-2 and CerebrovAscular DisordErs (CASCADE)
    Shahram Abootalebi, Benjamin M. Aertker, Mohammad Sobhan Sheikh Andalibi, Negar Asdaghi, Özlem Aykaç, Mahmoud Reza Azarpazhooh, Maria Cecilia Bahit, Kristian Barlinn, Hamidon Basri, Reza Bavarsad Shahripour et al. · 2020 · Journal of Stroke and Cerebrovascular Diseases
26. Reconfiguring the scope and practice of regional anesthesia in a pandemic: the COVID-19 perspective
    Balakrishnan Ashokka, Arunangshu Chakraborty, Balavenkat J Subramanian, Manoj Kumar Karmakar, Vincent W. S. Chan · 2020 · Regional Anesthesia & Pain Medicine
27. The advantages of peritoneal dialysis over hemodialysis during the COVID‐19 pandemic
    Tz‐Heng Chen, Yu‐Hua Wen, Chun-Fan Chen, Ann Charis Tan, Yung‐Tai Chen, Fan-Yu Chen, Chih‐Ching Lin · 2020 · Seminars in Dialysis
28. Cardio‐Oncology in the Era of the COVID‐19 Pandemic and Beyond
    Daniel Addison, Courtney M. Campbell, Avirup Guha, Arjun Kumar Ghosh, Susan Faye Dent, Hani M. Jneid · 2020 · Journal of the American Heart Association
29. Association of history of cerebrovascular disease with severity of COVID-19
    Timo Siepmann, Annahita Sedghi, Jessica Barlinn, Katja de With, Lutz Mirow, Martin Wolz, Thomas Gruenewald, Sina Helbig, Percy Schröttner, Simon Winzer et al. · 2020 · Journal of Neurology
30. Protein reliability analysis and virtual screening of natural inhibitors for SARS-CoV-2 main protease (M pro ) through docking, molecular mechanic & dynamic, and ADMET profiling
    Каріна Капуста, Supratik Kar, Jasmine T. Collins, Latasha M. Franklin, Wojciech Kołodziejczyk, Jerzy Leszczyński, Glake Hill · 2020 · Journal of Biomolecular Structure and Dynamics
31. COVID-19 and hypertension: is the HSP60 culprit for the severe course and worse outcome?
    Hrvoje Jakovac · 2020 · American Journal of Physiology-Heart and Circulatory Physiology
32. Praca zdalna podczas epidemii COVID-19 w Polsce - wyniki badania empirycznego
    Piotr Śliż · 2020 · e-mentor
33. Therapeutic Approach against 2019-nCoV by Inhibition of ACE-2 Receptor
    Gajendra Kumar, Dharmendra Kumar, Netra Pal Singh · 2020 · Drug Research
34. Clinical Characteristics and Survival Analysis in a Small Sample of Older COVID-19 Patients with Defined 60-Day Outcome
    Agnieszka Neumann‐Podczaska, Michał Chojnicki, Lukasz M. Karbowski, Salwan R. Al-Saad, Abbas A. Hashmi, Jerzy Tadeusz Chudek, Sławomir Tobis, Sylwia Kropińska, Iwona Mozer‐Lisewska, Aleksandra Suwalska et al. · 2020 · International Journal of Environmental Research and Public Health
35. Potential Therapeutic Role of Purinergic Receptors in Cardiovascular Disease Mediated by SARS‐CoV‐2
    Fernanda dos Anjos, Júlia Leão Batista Simões, Charles Elias Assmann, Fabiano B. Carvalho, Margarete Dulce Bagatini · 2020 · Journal of Immunology Research
36. Present cum future of SARS-CoV-2 virus and its associated control of virus-laden air pollutants leading to potential environmental threat – A global review
    Subhrajit Mukherjee, Soumendu Boral, Hammad Siddiqi, Asmita Mishra, Bhim Charan Meikap · 2021 · Journal of environmental chemical engineering
37. Level of the SARS-CoV-2 receptor ACE2 activity is highly elevated in old-aged patients with aortic stenosis: implications for ACE2 as a biomarker for the severity of COVID-19
    Miklós Fagyas, Attila Kertész, Ivetta Mányiné Siket, Viktor Bánhegyi, Bertalan Kracskó, Andrea Szegedi, M Szokol, Gusztáv Vajda, Ildikó Rácz, Hajnalka Gulyás et al. · 2021 · GeroScience
38. Targeting Endolysosomal Two-Pore Channels to Treat Cardiovascular Disorders in the Novel COronaVIrus Disease 2019
    Francesco Domenico Moccia, Sharon Negri, Pawan Sirwan Faris, Angelica Perna, Antonio De Luca, Teresa Soda, Roberto Berra‐Romani, Germano Guerra · 2021 · Frontiers in Physiology
39. Differences Between Pediatric Acute Myocarditis Related and Unrelated to SARS-CoV-2
    Vladislav A. Vukomanovic, Staša Krasić, Sergej Prijić, Sanja Ninić, Predrag B Minic, Gordana Petrović, Dejan Nešić · 2021 · The Pediatric Infectious Disease Journal
40. Abnormal upregulation of cardiovascular disease biomarker PLA2G7 induced by proinflammatory macrophages in COVID-19 patients
    Li Yang, Yongzhong Jiang, Yi Zhang, Naizhe Li, Qiangling Yin, Linlin Liu, Xin Lv, Yan Liu, Aqian Li, Bin Fang et al. · 2021 · Scientific Reports
41. The psychological impact of COVID-19 infection on athletes: example of professional male football players
    Yavuz Lima, Nevzad Denerel, Nazlı Deniz ÖZ, Seçkin Şenışık · 2021 · Science and Medicine in Football
42. Specific Treatment Exists for SARS-CoV-2 ARDS
    Badar A. Kanwar, Asif Khattak, Jong‐Hoon Lee, Jenny Balentine, R. E. Kast, Sang-Suk Oh, Consolato Sergi, Jong‐Hoon Lee · 2021 · Vaccines
43. Prevalência de Hipertensão Arterial Sistêmica e Diabetes Mellitus em Indivíduos com COVID-19: Um Estudo Retrospectivo de Óbitos em Pernambuco, Brasil
    Lucas Gomes Santos, Jussara Almeida de Oliveira Baggio, Thiago Cavalcanti Leal, Francisco A. Costa, Tânia Rita Moreno de Oliveira Fernandes, Regicley Vieira da Silva, Anderson Armstrong, Rodrigo Feliciano do Carmo, Carlos Dornels Freire de Souza · 2021 · Arquivos Brasileiros de Cardiologia
44. The Influence of COVID-19 Pandemic Lockdown on the Physical Performance of Professional Soccer Players: An Example of German and Polish Leagues
    Łukasz Radzimiński, Alexis Padrón-Cabo, Marek Konefał, Paweł Chmura, Andrzej Szwarc, Zbigniew Jastrzębski · 2021 · International Journal of Environmental Research and Public Health
45. Lessons learned in transitioning to AI in the medical imaging of COVID-19
    Issam M. El Naqa, Qiyuan Hu, Weijie Chen, Hui Li, Jordan D. Fuhrman, Naveena Gorre, Maryellen Lissak Giger · 2021 · Journal of medical imaging
46. Exploration of Human Serum Lipoprotein Supramolecular Phospholipids Using Statistical Heterospectroscopy in n-Dimensions (SHY-n): Identification of Potential Cardiovascular Risk Biomarkers Related to SARS-CoV-2 Infection
    Reika Masuda, Samantha Lodge, Luke Whiley, Nicola Gray, Nathan G. Lawler, Philipp Nitschke, Sze-How Bong, Torben Kimhofer, Ruey Leng Loo, Berin A. Boughton et al. · 2022 · Analytical Chemistry
47. Cardiac surgery on patients with COVID ‐19: a systematic review and meta‐analysis
    Aashray K. Gupta, Alasdair Leslie, Joseph N. Hewitt, Joshua George Kovoor, Christopher Dillon Ovenden, Suzanne Edwards, Justin C.Y. Chan, Michael George Worthington · 2022 · ANZ Journal of Surgery
48. Human lung organoid: Models for respiratory biology and diseases
    Wenhao Yang, Yingna Li, Fang Shi, Hanmin Liu · 2022 · Developmental Biology
49. A Systematic Review of Chest Imaging Findings in Long COVID Patients
    Somayeh Bazdar, Anastasia K. A. L. Kwee, Laura Houweling, Yolanda de Wit-van Wijck, Firdaus A. A. Mohamed Hoesein, George Stanley Downward, Esther J. Nossent, Anke H. Maitland‐van der Zee · 2023 · Journal of Personalized Medicine
50. Cardiac Biomarkers and Their Role in Identifying Increased Risk of Cardiovascular Complications in COVID-19 Patients
    Nagendra Yaluri, Alena Stančáková Yaluri, Pavol Žeňuch, Zuzana Žeňuchová, Štefan Tóth, Peter Marián Kalanin · 2023 · Diagnostics
51. Envisioned strategy for an early intervention in virus-suspected patients through non-invasive piezo- and pyro-electric-based wearable sensors
    Sujoy Kumar Ghosh, Dipankar Mandal · 2020 · Journal of Materials Chemistry A
52. Preparing IR for COVID-19: The Singapore Experience
    Apoorva Gogna, Sundeep Jaywantraj Punamiya, Anil Gopinathan, Farah Gillian Irani, Luke Han Wei Toh, Lawrence Hsueh Wen Cheong, Suresh Babu, Bernard Wee, Peter Goh, Bien Peng Tan et al. · 2020 · Journal of Vascular and Interventional Radiology
53. Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Pregnancy. A Non-systematic Review of Clinical Presentation, Potential Effects of Physiological Adaptations in Pregnancy, and Placental Vascular Alterations
    Paola Ayala‐Ramírez, Marcelo González, Carlos Escudero, Laura Quintero Arciniegas, Fernanda R. C. Giachini, Raiany Alves de Freitas, Alicia E. Damiano, Reggie García‐Robles · 2022 · Frontiers in Physiology
54. Reshaping the healthcare world by AI-integrated wearable sensors following COVID-19
    Bangul Khan, Rana Talha Khalid, Khair Ul Wara, M. Abul Masrur, Samiullah Khan, Wasim Ullah Khan, Umay Amara, Saad Abdullah · 2025 · Chemical Engineering Journal
55. COVID-19: Preliminary Clinical Guidelines for Ophthalmology Practices.
    Reza Gharebaghi, Jordan Desuatels, Majid Moshirfar, Maryam Parvizi, Seyed‐Hashem Daryabari, Fatemeh Heidary · 2020 · Medical Hypothesis Discovery & Innovation in Ophthalmology
56. What should a cardiologist know about coronavirus disease 2019?
    Grzegorz Sławiński, Ewa Lewicka · 2020 · Kardiologia Polska
57. COVID‐19, internists and resilience: the north‐south Italy outbreak
    Agostino Di Ciaula, Vincenzo Ostilio Palmieri, Giovanni Migliore, Piero Portincasa, the IMC‐19 Group · 2020 · European Journal of Clinical Investigation
58. COVID-19 Testing in Patients with Cancer: Does One Size Fit All?
    Ainhoa Madariaga, Michelle McMullen, Semira Sheikh, Rajat Kumar, Fei‐Fei Liu, Camilla Zimmermann, Shahid Husain, Gelareh Mohammed Zadeh, Amit M. Oza · 2020 · Clinical Cancer Research
59. COVID-19 and \ stroke: Incidental, triggered or causative
    Rohit Bhatia, M.V. Padma Srivastava · 2020 · Annals of Indian Academy of Neurology
60. The rapid transformation of cardiac surgery practice in the coronavirus disease 2019 (COVID-19) pandemic: Insights and clinical strategies from a center at the epicenter
    Isaac George, Michael P. Salna, Serge Kobsa, Scott C. DeRoo, Jacob M. Kriegel, David Blitzer, Nicholas J. Shea, Alex D'Angelo, Syed Tasnim Raza, Paul A. Kurlansky et al. · 2020 · Journal of Thoracic and Cardiovascular Surgery
61. Compact, Flexible Harmonic Transponder Sensor With Multiplexed Sensing Capabilities for Rapid, Contactless Microfluidic Diagnosis
    Liang Zhu, Haiyu Huang, Mark Ming‐Cheng Cheng, Pai‐Yen Chen · 2020 · IEEE Transactions on Microwave Theory and Techniques
62. OUTBREAK of novel corona virus disease (COVID-19): Antecedence and aftermath
    Ankit Awasthi, Sukriti Vishwas, Leander Corrie, Rajesh Kumar, Rubiya Khursheed, Jaskiran Kaur, Rajan Kumar, K.R. Arya, Monica Gulati, Bimlesh Kumar et al. · 2020 · European Journal of Pharmacology
63. COVID-19 outbreak: Challenges in pharmacotherapy based on pharmacokinetic and pharmacodynamic aspects of drug therapy in patients with moderate to severe infection
    Parisa Ghasemiyeh, Soliman Mohammadi‐Samani · 2020 · Heart & Lung
64. The Potential Role of Coagulation Factor Xa in the Pathophysiology of COVID-19: A Role for Anticoagulants as Multimodal Therapeutic Agents
    Galit H. Frydman, Michael Blake Streiff, Jean M. Connors, Gregory Piazza · 2020 · TH Open
65. Designed variants of ACE2-Fc that decouple anti-SARS-CoV-2 activities from unwanted cardiovascular effects
    Pan Liu, Xinfang Xie, Li Gao, Jing Jin · 2020 · International Journal of Biological Macromolecules
66. COVID-19 and Major Organ Thromboembolism: Manifestations in Neurovascular and Cardiovascular Systems
    Presaad Pillai, Joyce Pauline Joseph, Nurul Huda Mohamad Fadzillah, Masliza Mahmod · 2020 · Journal of Stroke and Cerebrovascular Diseases
67. Comorbidities and severity of coronavirus disease 2019 patients
    Radwan, Nashwa M., Mahmoud, Nagla E., Alfaifi, Amal H., Alabdulkareem, Khaled I. · 2020 · Saudi Medical Journal
68. Inflammatory-Related Clinical and Metabolic Outcomes in COVID-19 Patients
    María Martínez‐Urbistondo, Alberto Mora Vargas, Esther Expósito-Palomo, Raquel Castejón, María Jesús Citores, Silvia Rosado, Carmen de Mendoza, Isolina Baños, Ana Fernández‐Cruz, Lidia Daimiel et al. · 2020 · Mediators of Inflammation
69. Design and in silico study of the novel coumarin derivatives against SARS-CoV-2 main enzymes
    Mücahit Özdemir, Baybars Köksoy, Deniz Ceyhan, Koray Sayın, Erol Erçağ, Mustafa Bulut, Bahattin Yalçın · 2020 · Journal of Biomolecular Structure and Dynamics
70. Essential role of quantum science and nanoscience in antiviral strategies for COVID-19
    Mina Zare, Mika E. T. Sillanpää, Seeram Ramakrishna · 2021 · Materials Advances
71. Cardiovascular Injury Due to SARS-CoV-2
    Christina L. Bugert, Victoria R. Kwiat, Isela Valera, Joachim J. Bugert, Michelle S. Parvatiyar · 2021 · Current Clinical Microbiology Reports
72. Ultramicronized Palmitoylethanolamide (um-PEA): A New Possible Adjuvant Treatment in COVID-19 patients
    Annalisa Noce, Maria Albanese, Giulia Marrone, Manuela Di Lauro, Anna Pietroboni Zaitseva, Daniela Palazzetti, Cristina Guerriero, Agostino Paolino, Giuseppa Pizzenti, Francesca Di Daniele et al. · 2021 · Pharmaceuticals
73. Human Pluripotent Stem Cell-Derived Cardiac Cells: Application in Disease Modeling, Cell Therapy, and Drug Discovery
    Juan Huang, Qi Feng, Li Wang, Bingying Zhou · 2021 · Frontiers in Cell and Developmental Biology
74. Perspective: Wearable Internet of Medical Things for Remote Tracking of Symptoms, Prediction of Health Anomalies, Implementation of Preventative Measures, and Control of Virus Spread During the Era of COVID-19
    Sarmad Mehrdad, Yao Wang, S. Farokh Atashzar · 2021 · Frontiers in Robotics and AI
75. Nanobased Platforms for Diagnosis and Treatment of COVID-19: From Benchtop to Bedside
    Elham Bidram, Yasaman Esmaeili, Abbas Amini, Rossella Sartorius, Franklin R. Tay, Laleh Shariati, Pooyan Makvandi · 2021 · ACS Biomaterials Science & Engineering
76. Roborovski hamster (Phodopus roborovskii) strain SH101 as a systemic infection model of SARS-CoV-2
    Chong-Kai Zhai, Ming-Da Wang, Hea-Jong Chung, Mehedi Hassan, Seungkoo Lee, Hyeon-Jin Kim, Seong-Tshool Hong · 2021 · Virulence
77. Tissue-engineered heart chambers as a platform technology for drug discovery and disease modeling
    Ali Mousavi, Evan Stefanek, Arman Jafari, Zineb Ajji, Saman Naghieh, Mohsen Akbari, Houman Savoji · 2022 · Biomaterials Advances
78. A narrative review on yoga: a potential intervention for augmenting immunomodulation and mental health in COVID-19
    Indranill Basu‐Ray, Kashinath Metri, Dibbendhu Khanra, Rishab R. Revankar, Kavitha M. Chinnaiyan, Nagaratna Raghuram, Mahesh Chandra Mishra, Bhushan Patwardhan, Manjunath Sharma, Ishwar V. Basavaraddi et al. · 2022 · BMC Complementary Medicine and Therapies
79. Functional Effects of Cardiomyocyte Injury in COVID-19
    Mustafa M. Siddiq, Angel T. Chan, Lisa Miorin, Arjun Singh Yadaw, Kristin G. Beaumont, Thomas Kehrer, Anastasija Čupić, Kris M. White, Rosa E. Tolentino, Bin Hu et al. · 2021 · Journal of Virology
80. Cardiovascular effects of the post-COVID-19 condition
    Erin Goerlich, Tae Chung, Gloria H. Hong, Thomas Stephen Metkus, Nisha Aggarwal Gilotra, Wendy S. Post, Allison G. Hays · 2024 · Nature Cardiovascular Research
81. COVID-19 pandemic and therapy with ibuprofen or renin-angiotensin system blockers: no need for interruptions or changes in ongoing chronic treatments
    Oliver Zolk, Susanne Häfner, Christoph Q. Schmidt · 2020 · Naunyn-Schmiedeberg s Archives of Pharmacology
82. Cardiac sequelae of novel coronavirus disease 2019 (COVID-19): a clinical case series
    Zachary Dean Demertzis, Carina Dagher, Kelly Malette, Raef Ali Fadel, Patrick Bradley, Indira Brar, Bobak T. Rabbani, Geehan Suleyman · 2020 · European Heart Journal - Case Reports
83. The saudi critical care society clinical practice guidelines on the management of COVID-19 patients in the intensive care unit
    Waleed A. Alhazzani, Faisal A. Al-Suwaidan, Zohair Ahmed Al Aseri, Abbas Saleh Al Mutair, Ghassan Alghamdi, AliA Rabaan, Mohmmed Algamdi, Ahmed F. Alohali, AyedY Asiri, MohammedS Alshahrani et al. · 2020 · Saudi Critical Care Journal
84. Could Mesenchymal Stem Cell-Derived Exosomes Be a Therapeutic Option for Critically Ill COVID-19 Patients?
    Chiara Gardin, Letizia Ferroni, Juan Carlos Chachques, Barbara Zavan · 2020 · Journal of Clinical Medicine
85. Takotsubo cardiomyopathy in COVID-19: a case report. Haemodynamic and therapeutic considerations
    Dirk van Osch, Folkert Wouter Asselbergs, Arco J. Teske · 2020 · European Heart Journal - Case Reports
86. Noncoding RNAs implication in cardiovascular diseases in the COVID-19 era
    Simona Greco, Alisia Madè, Carlo Gaetano, Yvan Devaux, Costanza Emanueli, Fabio Martelli · 2020 · Journal of Translational Medicine
87. Heparin-binding protein levels correlate with aggravation and multiorgan damage in severe COVID-19
    Mingshan Xue, Yifeng Zeng, Hui‐Qi Qu, Teng Zhang, Ning Li, Huimin Huang, Peiyan Zheng, Haisheng Hu, Luqian Zhou, Zhifeng Duan et al. · 2020 · ERJ Open Research
88. Transcriptional Differences for COVID-19 Disease Map Genes between Males and Females Indicate a Different Basal Immunophenotype Relevant to the Disease
    Tianyuan Liu, Leandro Balzano‐Nogueira, Ana Lleò, Ana Conesa · 2020 · Genes
89. Lung and Kidney ACE2 and TMPRSS2 in Renin-Angiotensin System Blocker–Treated Comorbid Diabetic Mice Mimicking Host Factors That Have Been Linked to Severe COVID-19
    Ada Admin, Sri Nagarjun Batchu, Harmandeep Kaur, Veera Ganesh Yerra, Suzanne L. Advani, Golam Kabir, Youan Liu, Thomas Klein, Andrew Advani · 2020 · Diabetes
90. Essential roles of the dystrophin-glycoprotein complex in different cardiac pathologies
    Isela Valera, Amanda L. Wacker, Hyun Seok Hwang, Christina A. Holmes, Orlando Laitano, Andrew Paul Landstrom, Michelle S. Parvatiyar · 2020 · Advances in Medical Sciences
91. Entropy Analysis of COVID-19 Cardiovascular Signals
    Dragana Bajić, Vlado Đajić, Branislav Milovanović · 2021 · Entropy
92. Molecular features similarities between SARS-CoV-2, SARS, MERS and key human genes could favour the viral infections and trigger collateral effects
    Lucas L. Maldonado, Andrea Mendoza Bertelli, Laura Kamenetzky · 2021 · Scientific Reports
93. Neuropathies and neurological dysfunction induced by coronaviruses
    Mina Gholami, Sepideh Safari, Luis Ulloa, Majid Motaghinejad · 2021 · Journal of NeuroVirology
94. Geographical Detector-Based Spatial Modeling of the COVID-19 Mortality Rate in the Continental United States
    Han Yue, Tao Hu · 2021 · International Journal of Environmental Research and Public Health
95. Toward nanotechnology-enabled face masks against SARS-CoV-2 and pandemic respiratory diseases
    Nazek El‐Atab, Rishabh Mishra, Muhammad M. Hussain · 2021 · Nanotechnology
96. Evolution of Echocardiographic Abnormalities Identified in Previously Healthy Individuals Recovering from COVID-19
    Cristina Tudoran, Mariana Tudoran, Talida Georgiana Cut, Voichița Elena Lăzureanu, Cristian Iulian Oancea, Adelina Raluca Marinescu, Silvius Alexandru Pescariu, Gheorghe Nicușor Pop, Felix Bende · 2022 · Journal of Personalized Medicine
97. Myocardial injury in hospitalized COVID-19 patients: a retrospective study, systematic review, and meta-analysis
    Khalid Changal, Spiro Veria, Sean T. Mack, David Paternite, Shoaib Altaf Sheikh, Mitra Patel, Tanveer Mir, Mujeeb A. Sheikh, P. Kasi Ramanathan · 2021 · BMC Cardiovascular Disorders
98. Cold atmospheric plasma for addressing the COVID‐19 pandemic
    Zhitong Chen, Fan Bai, Steven John Jonas, Richard E. Wirz · 2022 · Plasma Processes and Polymers
99. Synergistic action of organophosphates and COVID-19 on inflammation, oxidative stress, and renin-angiotensin system can amplify the risk of cardiovascular maladies
    Prem Rajak, Sumedha Roy, Sayanti Podder, Moumita Dutta, Saurabh Sarkar, Abhratanu Ganguly, Moutushi Mandi, Anik Dutta, Sayantani Nanda, Salma Khatun · 2022 · Toxicology and Applied Pharmacology
100. Heart rate estimation network from facial videos using spatiotemporal feature image
     Kokila Bharti Jaiswal, Toshanlal Meenpal · 2022 · Computers in Biology and Medicine